|
C1ORF174 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.04150021940086E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.14069997891875E-09 |
| Normal-vs-Stage2 |
6.5654000014348E-08 |
| Normal-vs-Stage3 |
2.79000045289024E-10 |
| Normal-vs-Stage4 |
2.30449999971682E-07 |
| Stage1-vs-Stage2 |
7.708400E-02 |
| Stage1-vs-Stage3 |
6.243800E-02 |
| Stage1-vs-Stage4 |
3.094000E-01 |
| Stage2-vs-Stage3 |
7.271400E-01 |
| Stage2-vs-Stage4 |
5.609200E-01 |
| Stage3-vs-Stage4 |
7.266800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81859971526421E-10 |
| Normal-vs-AfricanAmerican |
3.77070000000534E-05 |
| Normal-vs-Asian |
1.940540E-03 |
| Caucasian-vs-AfricanAmerican |
6.737200E-01 |
| Caucasian-vs-Asian |
3.060300E-02 |
| AfricanAmerican-vs-Asian |
6.898100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.80859999596461E-08 |
| Normal-vs-Female |
7.76345654429633E-12 |
| Male-vs-Female |
3.488200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.67430000156344E-09 |
| Normal-vs-Age(41-60Yrs) |
1.80000000460367E-08 |
| Normal-vs-Age(61-80Yrs) |
5.80291370511077E-12 |
| Normal-vs-Age(81-100Yrs) |
4.76149999995013E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.457600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.033780E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.268400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.130100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.152400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.312600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.371190E-01 |
| Classical-VS-Follicular |
6.359600E-04 |
| Classical-VS-Other |
8.676000E-01 |
| Classical-VS-Normal |
1.92680005284274E-09 |
| Tall-VS-Follicular |
2.761000E-01 |
| Tall-VS-Other |
7.681800E-01 |
| Tall-VS-Normal |
1.64410000003112E-06 |
| Follicular-VS-Other |
3.933200E-01 |
| Follicular-VS-Normal |
2.03170036350286E-10 |
| Other-VS-Normal |
3.032400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.23189968915494E-10 |
| Normal-vs-N1 |
2.09780004478688E-09 |
| N0-vs-N1 |
2.592400E-01 |
|
|
